Agomelatine, a novel therapeutic option for the management of irritable bowel syndrome
Journal of Clinical Pharmacy and Therapeutics, EarlyView.
Source: Journal of Clinical Pharmacy and Therapeutics - Category: Drugs & Pharmacology Authors: Qin Xiang
Ng
MBBS
,
Alex Yu Sen
Soh
MBBS, MRCP
,
Donovan Yutong
Lim
MBBS, MMed
,
Wee ‐Song
Yeo
MBBS, FRCPCH, FRCP, FASN, PhD Source Type: research
More News: Irritable Bowel Syndrome